Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

1 min read Deep Health AI India

Company Update

Company Update

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Deep Health AI India Ltd #DDIL #Corporate announcement
NSE & BSE alerts on WhatsApp or Telegram

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

500
Companies on Pro
24/7
Automated alerts
Start Free Now
What you get
Free plan included
₹0 to start
Insider Deals Alert
Volume Breakout Detection (Purly informational)
FII/DII Trade Deals
Block Deals Notifications
Preferential Issue Alerts
Track up to 50 companies
No credit card required. Connect WhatsApp or Telegram in minutes.